Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment
about
Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin LymphomaNovel and emerging targeted-based cancer therapy agents and methods.A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemiaA synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2.Prediction of survival of diffuse large B-cell lymphoma patients via the expression of three inflammatory genes.Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies.Ibrutinib-A double-edge sword in cancer and autoimmune disorders.The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies.Ibrutinib for mantle cell lymphoma.Novel agents in mantle cell lymphoma.Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma.Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes
P2860
Q33622342-4CFD7F5E-3794-419E-A392-CB8D1D04A9E9Q34534572-F20B083F-D9DD-4981-ACC5-671ED9293094Q35558057-FD2B317F-C56E-4A68-A456-24B48758ACB4Q35794593-36B99793-7724-4D34-BCB7-A123DAE1E3F8Q36413780-4BAB7D27-0383-4D3A-9C04-B4A7FCF3B9FFQ37148950-8027AF26-6328-4C44-9EA5-945589D964B1Q38240579-7B6B5425-225C-46AA-8600-75C4ED6F7D9EQ38351184-87CA5380-EC54-489B-87B7-7F7F3AAFA688Q38585329-BDEF33B7-7AC6-4875-8CF6-86E934A7A7A0Q38664822-8F36287B-1977-4A84-89AC-C2FA7B142C6DQ38694168-4A33ED03-4AF9-4672-AFC4-1610F833B95BQ39290199-05AB681A-1531-4012-937A-32E0CA421F5AQ45594363-42C64A24-14D8-4BC1-AD28-95F427AF67ABQ58737485-71A0A179-1298-44FA-BD39-9B72FF985F9F
P2860
Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Different sensitivity of germi ...... ls towards ibrutinib treatment
@en
type
label
Different sensitivity of germi ...... ls towards ibrutinib treatment
@en
prefLabel
Different sensitivity of germi ...... ls towards ibrutinib treatment
@en
P2093
P2860
P356
P1476
Different sensitivity of germi ...... ls towards ibrutinib treatment
@en
P2093
Lixia Feng
Xiaohui Zheng
Yuqin Song
P2860
P2888
P356
10.1186/1475-2867-14-32
P577
2014-04-03T00:00:00Z
P5875
P6179
1005575382